dc.contributor.author
Heilmann, S.
dc.contributor.author
Küchler, S.
dc.contributor.author
Schäfer-Korting, M.
dc.date.accessioned
2018-06-08T02:56:45Z
dc.date.available
2015-07-21T08:55:35.770Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/14186
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-18383
dc.description.abstract
For patients with severe skin wounds, topically applied morphine is an option
to induce efficient analgesia due to the presence of opioid receptors in the
skin. However, for topical administration it is important to know whether the
substance is biotransformed in the skin as this can eventually reduce the
concentration of the active agent considerably. We use skin microsomes to
elucidate the impact of skin metabolism on the activity of topically applied
morphine. We are able to demonstrate that morphine is only glucuronidated in
traces, indicating that the biotransformation in the skin can be neglected
when morphine is applied topically. Hence, there is no need to take
biotransformation into account when setting up the treatment regimen.
en
dc.rights.uri
http://www.karger.com/Journal/Guidelines/238704#15
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::615 Pharmakologie, Therapeutik
dc.title
Morphine Metabolism in Human Skin Microsomes
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation
Skin Pharmacology and Physiology. - 25 (2012), 6, S. 319-322
dcterms.bibliographicCitation.doi
10.1159/000342067
dcterms.bibliographicCitation.url
http://www.karger.com/Article/FullText/342067
refubium.affiliation
Biologie, Chemie, Pharmazie
de
refubium.mycore.fudocsId
FUDOCS_document_000000022860
refubium.resourceType.isindependentpub
no
refubium.mycore.derivateId
FUDOCS_derivate_000000005232
dcterms.accessRights.openaire
open access